semaglutide Popular weight-loss drugs Ozempic and Wegovy may slow biological aging Compound Semaglutide

One study on semaglutide reported an average 6-months weight loss of approximately 11.5 kg (roughly 10%15% of baseline weight) and observed a high proportion of improvement in menstrual cycles (39)

The risks of microdosing are significant and multifaceted: Therapeutic inefficacy : Sub-therapeutic doses may fail to achieve meaningful improvements in glycaemic control or weight management, potentially delaying appropriate treatment and allowing disease progression

If you are interested in weight loss support you can start a consultation here

This creamy chicken & rice soup meets you exactly where you are queasy, tired, overwhelmed, or just needing a pause